Results 311 to 320 of about 177,383 (332)
Some of the next articles are maybe not open access.

Inflammasome and Atherogenesis

Current Pharmaceutical Design, 2014
Atherosclerosis is a progressive disease starting with accumulation of lipids, lipoproteins, and immune cells in the arterial wall. Inflammation and the innate immune response are involved in the formation of early atherosclerotic lesion. A protein complex known as the inflammasome is stimulated to activate interleukin-1β (IL-1β) and IL-18, which are ...
Xinjie, Lu, Vijay, Kakkar
openaire   +2 more sources

Leukadherin-1 inhibits NLRP3 inflammasome by blocking inflammasome assembly

International Immunopharmacology, 2023
Aberrant activation of the NLRP3 inflammasome has been implicated in the occurrence and development of many inflammatory diseases, and thus potent inhibitors of the NLRP3 inflammasome should be explored. An antitumor agent, Leukadherin-1 (LA-1), tested in phase 1/2 clinical trials, has been reported to exert anti-inflammatory properties by blocking the
Yening Zhang   +5 more
openaire   +2 more sources

Autophagy and inflammasomes

Molecular Immunology, 2017
Autophagy is a ubiquitous cellular mechanism for the targeted lysosomal degradation of various cytosolic constituents, from proteins to organelles. As an essential homeostatic mechanism, autophagy is upregulated in response to numerous environmental and pharmacological stimuli, including starvation, where it facilitates the recycling of essential amino
James, Harris   +5 more
openaire   +2 more sources

Taming the inflammasome

Nature Medicine, 2015
The NLRP3 inflammasome is involved in the molecular etiology of multiple autoinflammatory diseases. Two studies identify inhibitors of NLRP3 activation and might pave the way for new treatment options for a variety of diseases.
Maayan, Levy   +2 more
openaire   +2 more sources

Inflammasome and Cancer

2018
The current chapter focuses on the role of inflammasome in cancer prevention and development. Emerging evidence suggested that inflammasome is closely correlated with elevated levels of IL-1β and IL-18, activation of NF-κB signaling, enhanced mitochondrial oxidative stress, and activation of autophagic process in cancer.
Zhiyu, Wang   +3 more
openaire   +2 more sources

Genetics of Inflammasomes

2018
Mutations in inflammasome genes are responsible for rare monogenic and polygenic autoinflammatory diseases. On the other side, genetic polymorphisms in the same molecules contribute to the development of common multifactorial diseases (i.e., autoimmune diseases, cardiovascular pathologies, cancer).
Wanessa Cardoso, da Silva   +3 more
openaire   +2 more sources

Quieting the inflammasome

Nature Reviews Immunology, 2012
Autophagosome formation accompanies inflammasome activation and acts to limit inflammasome activity.
openaire   +2 more sources

Streptococci target inflammasome

Nature Microbiology, 2017
The Streptococcus pyogenes surface M protein is a critical multifunctional virulence factor. Recent work sheds light on a new unexpected function of the M protein in activating the host inflammasome to induce macrophage cell death and promote infection.
openaire   +2 more sources

Inflammasome-independent pyroptosis

Current Opinion in Immunology
Gasdermins are membrane pore-forming proteins that cause pyroptosis, an inflammatory cell death in which cells burst and release cytokines, chemokines, and other host alarm signals, such as ATP and HMGB1, which recruit and activate immune cells at sites of infection and danger. There are five gasdermins in humans - gasdermins A to E.
Xing, Liu, Judy, Lieberman
openaire   +2 more sources

Inflammasome

Materials and Methods, 2020
Tao Gong, Rongbin Zhou
openaire   +2 more sources

Home - About - Disclaimer - Privacy